Rockefeller Capital Management L.P. Ironwood Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$10.14 - $12.38 $1,003 - $1,225	99 New	99 $1,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $1,390 - $1,785	-128 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $1,525 - $1,781	128 New	128 $1,000
Q4 2020 Feb 12, 2021	SELL	$9.05 - $12.2 $1,402 - $1,891	-155 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$8.99 - $10.74 $943 - $1,127	-105 Reduced 40.38%	155 $1,000
Q2 2020 Aug 12, 2020	SELL	$9.14 - $11.97 $27,483 - $35,993	-3,007 Reduced 92.04%	260 $3,000
Q1 2020 May 12, 2020	BUY	$8.58 - $14.01 $5,053 - $8,251	589 Added 21.99%	3,267 $33,000
Q1 2018 May 09, 2018	BUY	$11.13 - $13.63 $29,806 - $36,501	2,678 New	2,678 $41,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.